These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


117 related items for PubMed ID: 32554173

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The pattern of symptom change during prolonged exposure therapy and present-centered therapy for PTSD in active duty military personnel.
    Brown LA, Clapp JD, Kemp JJ, Yarvis JS, Dondanville KA, Litz BT, Mintz J, Roache JD, Young-McCaughan S, Peterson AL, Foa EB, STRONG STAR Consortium.
    Psychol Med; 2019 Sep; 49(12):1980-1989. PubMed ID: 30220261
    [Abstract] [Full Text] [Related]

  • 5. Cortisol augmentation of a psychological treatment for warfighters with posttraumatic stress disorder: Randomized trial showing improved treatment retention and outcome.
    Yehuda R, Bierer LM, Pratchett LC, Lehrner A, Koch EC, Van Manen JA, Flory JD, Makotkine I, Hildebrandt T.
    Psychoneuroendocrinology; 2015 Jan; 51():589-97. PubMed ID: 25212409
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prolonged Exposure Therapy With Veterans and Active Duty Personnel Diagnosed With PTSD and Traumatic Brain Injury.
    Wolf GK, Kretzmer T, Crawford E, Thors C, Wagner HR, Strom TQ, Eftekhari A, Klenk M, Hayward L, Vanderploeg RD.
    J Trauma Stress; 2015 Aug; 28(4):339-47. PubMed ID: 26201688
    [Abstract] [Full Text] [Related]

  • 10. Design of a randomized controlled trial examining the efficacy and biological mechanisms of web-prolonged exposure and present-centered therapy for PTSD among active-duty military personnel and veterans.
    McLean CP, Rauch SAM, Foa EB, Sripada RK, Tannahill HS, Mintz J, Yarvis J, Young-McCaughan S, Dondanville KA, Hall-Clark BN, Fina BA, Keane TM, Peterson AL, STRONG STAR Consortium and the Consortium to Alleviate PTSD.
    Contemp Clin Trials; 2018 Jan; 64():41-48. PubMed ID: 29128649
    [Abstract] [Full Text] [Related]

  • 11. Changes in Salivary Cortisol During Psychotherapy for Posttraumatic Stress Disorder: A Pilot Study in 30 Veterans.
    Rauch SAM, King AP, Liberzon I, Sripada RK.
    J Clin Psychiatry; 2017 May; 78(5):599-603. PubMed ID: 28102979
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effects of web-prolonged exposure among military personnel and veterans with posttraumatic stress disorder.
    McLean CP, Foa EB, Dondanville KA, Haddock CK, Miller ML, Rauch SAM, Yarvis JS, Wright EC, Hall-Clark BN, Fina BA, Litz BT, Mintz J, Young-McCaughan S, Peterson AL, STRONG STAR Consortium.
    Psychol Trauma; 2021 Sep; 13(6):621-631. PubMed ID: 33211517
    [Abstract] [Full Text] [Related]

  • 15. Cortisol awakening response in PTSD treatment: Predictor or mechanism of change.
    Rauch SAM, King A, Kim HM, Powell C, Rajaram N, Venners M, Simon NM, Hamner M, Liberzon I.
    Psychoneuroendocrinology; 2020 Aug; 118():104714. PubMed ID: 32446108
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Reducing suicidal ideation through evidence-based treatment for posttraumatic stress disorder.
    Cox KS, Mouilso ER, Venners MR, Defever ME, Duvivier L, Rauch SAM, Strom TQ, Joiner TE, Tuerk PW.
    J Psychiatr Res; 2016 Sep; 80():59-63. PubMed ID: 27295122
    [Abstract] [Full Text] [Related]

  • 19. Pretreatment cortisol predicts trauma-focused psychotherapy response in youth with (partial) posttraumatic stress disorder.
    Zantvoord JB, Ensink JBM, Op den Kelder R, Wessel AMA, Lok A, Lindauer RJL.
    Psychoneuroendocrinology; 2019 Nov; 109():104380. PubMed ID: 31352130
    [Abstract] [Full Text] [Related]

  • 20. Integrating biological treatment mechanisms into randomized clinical trials: Design of PROGrESS (PROlonGed ExpoSure and Sertraline Trial).
    Rauch SAM, Simon NM, Kim HM, Acierno R, King AP, Norman SB, Venners MR, Porter K, Phan KL, Tuerk PW, Allard C, Liberzon I, Rothbaum BO, Martis B, Stein MB, Hoge CW.
    Contemp Clin Trials; 2018 Jan; 64():128-138. PubMed ID: 29081351
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.